A Clinical Study of Children With Status Epilepticus in China
NCT03378687 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2017-12-20
Summary
Phase 1: The first part of study is a multi-center, retrospect study involving 38 hospitals. The program is a national epidemiological study on status epilepticus in Chinese children.The aims of the epidemiological study include:
1. to obtain national epidemiological data on the etiology, diagnosis,treatment,evaluation, risk factors , outcome and analyze the burden of disease.
2. to build a Collaborative Network in pediatric status epilepticus research.
3. to establish a national clinical database of pediatric status epilepticus.
4. to lay the foundation for the further prospective study.
Phase 2: The second part of study is a multi-center, prospective study involving 38 hospitals. The aim of the study is to set up guideline of Children with SE in China.
Conditions
- Status Epilepticus
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Yi Wang, PhD,MD · Children's Hospital of Fudan University
Eligibility
- Min Age
- 29 Days
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2019-09-30
- Completion
- 2019-09-30
Countries
- China
Study Locations
More Related Trials
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
Pediatric Epilepsy Trial in Subjects 1-24 Months
NCT00043875 ·Status: COMPLETED ·Phase: PHASE2
-
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT04290975 ·Status: COMPLETED ·Phase: NA
-
Epilepsy Prevalence and Intervention Study in Zhejiang Province, China
NCT04944641 ·Status: UNKNOWN ·Phase: NA
-
Pediatric Epilepsy Study in Subjects 1-24 Months
NCT00044278 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Epilepsy
NCT02889627 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure
NCT05257915 ·Status: UNKNOWN
-
Creation, Implementation, and Analysis of a Seizure Action Plan
NCT02995759 ·Status: COMPLETED
-
A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy
NCT04737837 ·Status: UNKNOWN
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
NCT00275912 ·Status: COMPLETED ·Phase: PHASE4
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
NCT00986310 ·Status: COMPLETED ·Phase: NA
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Nucleotide Protein -3 in Epileptic Children
NCT04219930 ·Status: UNKNOWN
-
Getting SMART for Pediatric Epilepsy
NCT05439876 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevalence and Pattern of Headache in Pediatric Epilepsy
NCT06868251 ·Status: NOT_YET_RECRUITING
-
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
NCT00144872 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
NCT04144218 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy
NCT05497193 ·Status: UNKNOWN
-
The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
NCT07095933 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Ketogenic Diet in Pediatric Intractable Epilepsy
NCT06310954 ·Status: RECRUITING ·Phase: NA
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED